<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>International Journal of Radiation Research</title>
<title_fa>نشریه پرتو پژوه</title_fa>
<short_title>Int J Radiat Res</short_title>
<subject>Basic Sciences</subject>
<web_url>http://ijrr.com</web_url>
<journal_hbi_system_id>79</journal_hbi_system_id>
<journal_hbi_system_user>journal79</journal_hbi_system_user>
<journal_id_issn>2322-3243</journal_id_issn>
<journal_id_issn_online>2345-4229</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61882/ijrr</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1399</year>
	<month>7</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2020</year>
	<month>10</month>
	<day>1</day>
</pubdate>
<volume>18</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Prognostic value of various metabolic parameters on pre-treatment 18-F-FDG PET/CT in patients with stage  I-III non-small cell lung cancer</title>
	<subject_fa>Medical Physics</subject_fa>
	<subject>Medical Physics</subject>
	<content_type_fa>تحقيق بديع</content_type_fa>
	<content_type>Original Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;Background: the aim of this study was to investigate the prognostic value of &lt;sup&gt;18&lt;/sup&gt;Fluorine-fluorodeoxyglucose positron emission tomography/computed tomography (&lt;sup&gt;18&lt;/sup&gt;F-FDG PET/CT) parameters in both overall survival and progression-free survival in Stage I-III non-small cell lung cancer (NSCLC). Materials and Methods: In this retrospective study, 267 patients who were diagnosed as Stage I-III non-small cell lung cancer and had undergone FDG-PET/CT imaging before treatment were included. PET/CT parameters, maximum and mean standardized uptake values (SUVmax and SUVmean), metabolic tumor volume (MTV), total lesional glycolysis (TLG), and maximum tumor-to-blood standard uptake ratio (SURmax) were calculated. Analyses were performed to evaluate the ability of PET parameters to predict recurrence and death as well as to determine prognostic value. Results: In predicting both mortality and progression, the area under the ROC curve (AUC) value was highest for TLG (AUC: 0.717, 0.692 respectively). Overall survival was lower in patients with TLG&gt; 214, and progression-free survival was lower in patients with TLG&gt; 194. All PET parameters had a prognostic value in univariate analysis. Age, N1 stage and SUVmean were independent prognostic factors in multivariate analysis. Conclusion: In predicting death and progression, TLG had the highest predictive value. Age and N1 stage were independent prognostic factors in multivariate analysis, while SUVmean was the most valuable independent prognostic factor.&lt;/div&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>18-F-PET/CT, non-small cell lung cancer, prognosis, survival.</keyword>
	<start_page>799</start_page>
	<end_page>807</end_page>
	<web_url>http://ijrr.com/browse.php?a_code=A-10-2055-66&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>F. </first_name>
	<middle_name></middle_name>
	<last_name>Demir</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>drfadimedemir@hotmail.com </email>
	<code>7900319475328460016960</code>
	<orcid>7900319475328460016960</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Nuclear Medicine, School of Medicine, Tokat Gaziosmanpasa University, Tokat, Turkey</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>A. </first_name>
	<middle_name></middle_name>
	<last_name>Yanarateş</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>7900319475328460016961</code>
	<orcid>7900319475328460016961</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Nuclear Medicine, Izmir Dr. Suat Seren Chest Diseases and Surgery Training and Research Hospital, University of Health Sciences, Izmir, Turkey</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
